4-145651070-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_172250.3(MMAA):c.742C>T(p.Gln248*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_172250.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMAA | NM_172250.3 | c.742C>T | p.Gln248* | stop_gained | Exon 5 of 7 | ENST00000649156.2 | NP_758454.1 | |
MMAA | NM_001375644.1 | c.742C>T | p.Gln248* | stop_gained | Exon 5 of 7 | NP_001362573.1 | ||
MMAA | XM_011531684.4 | c.742C>T | p.Gln248* | stop_gained | Exon 5 of 7 | XP_011529986.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251458Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135906
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Methylmalonic aciduria, cblA type Pathogenic:3
- -
ClinVar contains an entry for this variant (Variation ID: 496554). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This premature translational stop signal has been observed in individuals with methylmalonic aciduria cobalamin A type (PMID: 15523652, 25748407, 28497574). This variant is present in population databases (rs757548934, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Gln248*) in the MMAA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MMAA are known to be pathogenic (PMID: 15523652, 15781192). -
- -
Methylmalonic acidemia Pathogenic:1
Variant summary: The MMAA c.742C>T (p.Gln248X) variant results in a premature termination codon, predicted to cause a truncated or absent MMAA protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The truncated protein is expected to remove the 170 amino acids in the C-terminus, which includes part of the P-loop containing nucleoside triphosphate hydrolase domain. One in silico tool predicts a damaging outcome for this variant. Xiong_2015 predicted a large splicing change induced by this variant. However, this change was not predicted by 5/5 splice prediction tools. ESE finder predicts that this variant may affect multiple ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 4/121506 control chromosomes at a frequency of 0.0000329 (all alleles are from East Asian subpopuation), which does not exceed the estimated maximal expected allele frequency of a pathogenic MMAA variant (0.0018257). This variant has been reported in at least two patients. Taken together, this variant is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at